Literature DB >> 29708447

Prevalence and predictors of tobacco smoking in veterans and service members following traumatic brain injury rehabilitation: a VA TBIMS study.

Marc A Silva1,2,3,4, Heather G Belanger1,3,4,5, Kristen Dams-O'Connor6, Xinyu Tang7, Tamara McKenzie-Hartman3, Risa Nakase-Richardson1,3,4,8.   

Abstract

OBJECTIVE: To identify prevalence and predictors of tobacco smoking among veterans and military service members (V/SM) with traumatic brain injury (TBI) admitted for rehabilitation.
METHODS: Participants were drawn from the VA TBI Model Systems multicentre longitudinal research study. Tobacco smoking was assessed both preinjury and at 1- or 2-year post-TBI follow-up for 336 participants.
RESULTS: Smoking prevalence was 32% preinjury and 28% at follow-up. Most participants had a stable smoking pattern but 12% of preinjury non-smokers became smokers at follow-up. Preinjury smoking was the strongest predictor of post-TBI smoking. Higher cognitive function also predicted smoking at follow-up. In univariate analyses, smoking was predicted by lower education, preinjury mental health (MH) history, selected TBI severity metrics, and higher functional status at rehabilitation hospital discharge (Disability Rating Scale [DRS] and motor subscale of the Functional Independence Measure [FIM]).
CONCLUSION: Study findings may help clinicians and administrators recognize who is at high risk for smoking following TBI, to plan for in-hospital and postdischarge screening and interventions.

Entities:  

Keywords:  Brain Injuries; Traumatic; military personnel; tobacco smoking; veterans

Mesh:

Year:  2018        PMID: 29708447     DOI: 10.1080/02699052.2018.1468576

Source DB:  PubMed          Journal:  Brain Inj        ISSN: 0269-9052            Impact factor:   2.311


  1 in total

Review 1.  The Traumatic Brain Injury Model Systems National Database: A Review of Published Research.

Authors:  Samantha Tso; Ashirbani Saha; Michael D Cusimano
Journal:  Neurotrauma Rep       Date:  2021-03-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.